In its first earnings report since the departure of longtime CEO Joe Kiani, Masimo said Tuesday it is focused on reducing spending to drive long-term
Tempus AI agreed to buy genetic testing company Ambry Genetics for $375 million in cash and $225 million in shares. Chicago-based Tempus, which makes AI-enabled
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Advamed has asked for Medicare to cover
ScottsMiracle-Gro Reports Fiscal 2024 Fourth Quarter and Full-Year Results U.S. Consumer fiscal 2024 sales up 6 percent in line with guidance; POS units up 9
A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive and specific for detecting colorectal cancer (CRC) among Thai
Exhaled breath contains chemical clues to what’s going on inside the body, including diseases like lung cancer.
A Joint research team (Prof. Jun-hee Lee, Hyun-koo Kim, Jin-Wook Hwang, Jae-Ho Chung, the Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine)
The highest number of tuberculosis (TB) cases since global monitoring began were recorded in 2023, according to a report published by the World Health Organization
Intra-Cellular expects Caplyta to rake in about $665-685m in sales this year. Image credit: Lightspring / Shutterstock. Having raised the full-year sales guidance for Caplyta
Research reveals unmarried individuals face higher depression risks, influenced by alcohol and smoking, highlighting cultural impacts on mental health.